The impact of tralokinumab on quality of life and school in patients aged 12–17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s77, 2022. DOI: 10.25251/skin.6.supp.77. Disponível em: https://skin.dermsquared.com/skin/article/view/1835. Acesso em: 19 apr. 2025.